Flagship Ventures Fund IV General Partner LLC
Related Filers (33)
- Flagship Ventures Fund IV, L.P. (45)
- AFEYAN NOUBAR (43)
- Flagship Ventures Fund IV-Rx, L.P. (33)
- KANIA EDWIN M JR (26)
- Flagship Ventures Fund 2007, L.P. (16)
- Flagship Ventures 2007 General Partner LLC (16)
- Flagship VentureLabs IV, LLC (15)
- Flagship Ventures Opportunities Fund I, L.P. (13)
- Flagship Ventures Opportunities Fund I General Partner LLC (11)
- Moderna, Inc. (10)
- Eleven Biotherapeutics, Inc. (6)
- Rubius Therapeutics, Inc. (6)
- Evelo Biosciences, Inc. (6)
- Syros Pharmaceuticals, Inc. (5)
- Axcella Health Inc. (5)
- Nutritional Health LTP Fund General Partner LLC (5)
- Nutritional Health LTP Fund, L.P. (5)
- Flagship Pioneering Inc. (5)
- Seres Therapeutics, Inc. (4)
- Kaleido Biosciences, Inc. (4)
- Editas Medicine, Inc. (3)
- TransMedics Group, Inc. (3)
- Flagship Ventures Fund V, L.P. (3)
- T2 Biosystems, Inc. (2)
- Flagship Ventures General Partner LLC (2)
- Flagship Ventures Fund 2004 L P (2)
- Flagship V VentureLabs Rx Fund, L.P. (2)
- Cadena LLC (2)
- Flagship Pioneering Fund VI General Partner LLC (1)
- Flagship Pioneering Fund VI, L.P. (1)
- Flagship Ventures Fund V General Partner LLC (1)
- Flagship Pioneering Fund VII, L.P. (1)
- Flagship Pioneering Fund VII General Partner LLC (1)
- Show More ...
Other (33)
13F-NT
Wednesday, 2/14/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/16/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 8/13/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 5/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 2/13/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 11/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/13/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 2/13/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/13/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/7/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/15/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 2/14/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 11/3/2017
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 8/2/2017
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 5/10/2017
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/13/2017
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2016
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-NT
Friday, 6/3/2016
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-HR
Friday, 2/12/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (54)
4
Thursday, 7/13/2023
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/17/2022
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Moderna, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Rubius Therapeutics, Inc.: Major Shareholders
4
Tuesday, 3/23/2021
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
Moderna, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Rubius Therapeutics, Inc.: Major Shareholders
4
Wednesday, 2/10/2021
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2021
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/25/2020
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2020
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/26/2020
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/20/2020
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/13/2020
Moderna, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/13/2020
Moderna, Inc.: Major Shareholders
4
Wednesday, 12/11/2019
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/31/2019
TransMedics Group, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/15/2019
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
Axcella Health Inc.: Initial statement of beneficial ownership of securities
4
Monday, 5/6/2019
TransMedics Group, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/1/2019
TransMedics Group, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/6/2019
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/27/2019
Kaleido Biosciences, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 2/13/2019
Rubius Therapeutics, Inc.: Major Shareholders
SC 13G
Tuesday, 2/12/2019
Moderna, Inc.: Major Shareholders
4
Thursday, 12/13/2018
Moderna, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/7/2018
Moderna, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/23/2018
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/17/2018
Rubius Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/15/2018
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/8/2018
Evelo Biosciences, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 8/21/2017
Syros Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 8/21/2017
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/26/2016
Eleven Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/21/2016
Eleven Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2016
Eleven Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/8/2016
Eleven Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/15/2016
Editas Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 7/11/2016
Syros Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 7/7/2016
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/29/2016
Syros Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/27/2016
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2016
Editas Medicine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/2/2016
Editas Medicine, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/29/2015
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/25/2015
Seres Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/14/2014
T2 Biosystems, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/6/2014
T2 Biosystems, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 2/13/2014
Eleven Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/5/2014
Eleven Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities